Donald A Bergstrom Insider Profile

4 Followers
Donald A Bergstrom, Chief Medical Officer at Mersana Therapeutics, holds ― shares in Mersana Therapeutics (Ticker: MRSN), holds 520.75K shares in Relay Therapeutics (Ticker: RLAY), holds ― shares in Fusion Pharmaceuticals (Ticker: FUSN). Most recently, Donald A Bergstrom ― shares of Mersana Therapeutics on ― for an estimated value of ―.
tipranks
Donald A Bergstrom

Donald A Bergstrom
Mersana Therapeutics (MRSN)
Chief Medical Officer

Ranked #935 out of 99,218 Corporate Insiders

Profitable Transactions

95%
21 out of 22 Profitable Transactions

Average Return

+33.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
0.00%
A breakdown of Donald A Bergstrom's holdings

Insider Roles

Relay Therapeutics
(RLAY)
President, R&D
Mersana Therapeutics
(MRSN)
Chief Medical Officer
Roles that Donald A Bergstrom holds in companies

Most Profitable Insider Trade

Stock:
Relay Therapeutics
(RLAY)
Rating:Informative Sell
Date:Sep 29, 2022 - Sep 29, 2023
Return:+63.60%
The most profitable trade made by Donald A Bergstrom

Donald A Bergstrom's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Mersana Therapeutics
Chief Medical Officer
Relay Therapeutics
Oct 30, 2024
President, R&D
Informative Sell
16.29K
$3.04M
FUSN
Fusion Pharmaceuticals
List of latest transactions for each holding click on a transaction to see Donald A Bergstrom's performance on stock

Donald A Bergstrom insider profile FAQ

What is the percentage of profitable transactions made by Donald A Bergstrom?
The percentage of profitable transactions made by Donald A Bergstrom is 95%.
    What is the average return per transaction made by Donald A Bergstrom?
    The average return per transaction made by Donald A Bergstrom is 33.40%.
      What stocks does Donald A Bergstrom hold?
      Donald A Bergstrom holds: MRSN, RLAY, FUSN stocks.
        What was Donald A Bergstrom’s latest transaction?
        Donald A Bergstrom latest transaction was an Uninformative Buy of ―.
          What was Donald A Bergstrom's most profitable transaction?
          Donald A Bergstrom’s most profitable transaction was an Informative Sell of RLAY stock on September 29, 2022. The return on the trade was 63.60%.
            What is Donald A Bergstrom's role in Mersana Therapeutics?
            Donald A Bergstrom's role in Mersana Therapeutics is Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.